Correction to: Perverse Results from Pharmaceutical Patents in the United States

被引：0

作者：

Warren Grimes

机构：

[1] Southwestern Law School,Irving D and Florence Rosenberg Professor of Law

来源：

IIC - International Review of Intellectual Property and Competition Law | 2022年 / 53卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：679 / 679

共 50 条

[1] Perverse Results from Pharmaceutical Patents in the United States
Warren Grimes
IIC - International Review of Intellectual Property and Competition Law, 2021, 52 : 596 - 605
[2] Perverse Results from Pharmaceutical Patents in the United States
Grimes, Warren
IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2021, 52 (05) : 596 - 605
[3] Perverse Results from Pharmaceutical Patents in the United States (vol 52, pg 596, 2022)
Grimes, Warren
IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2022, 53 (04) : 679 - 679
[4] Evaluating the use of provisional patents by the pharmaceutical industry: The experience of the United States
Beyer, A. P.
Visaria, J.
Seoane-Vazquez, E.
Szeinbach, S. L.
VALUE IN HEALTH, 2008, 11 (03) : A33 - A33
[5] STORY OF UNITED-STATES PATENT OFFICE AND PATENTS IN ACTION - PHARMACEUTICAL MANUFACTURES ASSOC
ROSSMAN, J
JOURNAL OF THE PATENT OFFICE SOCIETY, 1966, 48 (03): : 210 - 211
[6] Biotechnology patents in the United States
Schapira, R
BIOTECHNOLOGY, PATENTS AND MORALITY, 1997, : 171 - 172
[7] THE UNITED STATES PATENTS QUARTERLY
不详
JOURNAL OF THE PATENT OFFICE SOCIETY, 1939, 21 (02): : 153 - 154
[8] ENEMY PATENTS IN THE UNITED STATES
Holtzoff, Alexander
AMERICAN JOURNAL OF INTERNATIONAL LAW, 1932, 26 (02) : 272 - 279
[9] The perverse consequences of electoral reform in the united states
Berinsky, AJ
AMERICAN POLITICS RESEARCH, 2005, 33 (04) : 471 - 491
[10] An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
Timo Minssen
Aaron S Kesselheim
Jonathan J Darrow
Nature Biotechnology, 2019, 37 : 21 - 22

← 1 2 3 4 5 →